(Total Views: 226)
Posted On: 03/15/2021 7:51:01 AM
Post# of 36549
Based on Joe's statement in the PR from 19 days ago, I'm guessing that the next update should be about the IND.
Joseph Moscato, President & CEO of Generex stated, “We are preparing our IND submission for Phase I and II human clinical trials to evaluate safety and immunogenicity of the Ii-Key vaccine, and plan to submit the IND to the FDA as soon as the GMP production of the Ii-Key vaccine is completed in the coming weeks
Joseph Moscato, President & CEO of Generex stated, “We are preparing our IND submission for Phase I and II human clinical trials to evaluate safety and immunogenicity of the Ii-Key vaccine, and plan to submit the IND to the FDA as soon as the GMP production of the Ii-Key vaccine is completed in the coming weeks
(1)
(0)Scroll down for more posts ▼
